Inflammatory myopathies: Update on the molecular pathogenesis of inflammatory myopathies

Autoimmunity Reviews

Volumn 3, Issue SUPPL. 1, 2004, Pages

  Dalakas, M C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD52 ANTIGEN; CELL ADHESION MOLECULE; CHLORAMBUCIL; COMPLEMENT COMPONENT C5; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKINE; CYTOKINE RECEPTOR; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; METHOTREXATE; MONOCLONAL ANTIBODY;

CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DIAGNOSTIC APPROACH ROUTE; DRUG TARGETING; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INCLUSION BODY MYOSITIS; LYMPHOCYTE DEPLETION; MOLECULAR DYNAMICS; MYOSITIS; PATHOPHYSIOLOGY; POLYMYOSITIS; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TREATMENT INDICATION; ANIMAL; GENETICS; MOLECULAR BIOLOGY; PATHOLOGY; REVIEW;

ANIMALS; HUMANS; MOLECULAR BIOLOGY; MYOSITIS;

EID: 16644370519     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Dalakas M.C. Polymyositis, Dermatomyositis and Inclusion-Body Myositis. N. Engl. J. Med. 1991;325:1487-1498.
2. Dalakas M.C., Hohlfeld R. Polymyositis and Dermatomyositis. Lancet 2003; 362:971-982.
3. Dalakas M.C. Polymyositis, Dermatomyositis and Inclusion Body Myositis. In: Harrison's Principles of Internal Medicine (16th edition). Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., Jameson J.L. (eds). McGraw-Hill, New York, NY. In press.
4. Mastaglia F.L., Phillips B.A. Idiopathic inflammatory myopathies: epidemiology, classification and diagnostic criteria. Rheum Dis Clin N Am 2002; 28:23-41.
5. Griggs R.C., Askanas V., Di Mauro S., et al. Inclusion body myositis and myopathies. Ann. Neurol. 1995:38:705-713.
6. Dalakas M.C. Muscle biopsy findings in inflammatory myopathies. Rheum. Dis. Clin. N. Am. 2002; 28:779-98.
7. Hohlfeld R., Engel A.G. The immunobiology of muscle. Immunol. Today 1994;15:269-274.
8. Dalakas M.C., Hohlfeld R. Diagnostic criteria for Polymyositis and Dermatomyositis. Lancet 2003;362:1762-1763.
9. Bender A., Ernst N., Iglesias A., Dornmair K., Wekeria H., Hohlfeid R. T Cell Receptor repertoire in polymyositis: clonal expansion of autoaggresive CD8 T Cells. J. Exp. Med. 1995;181:1863-1868.
10. Amemiya K., Granger R.P., Dalakas M.C. Clonal restriction of T -cell receptor expression by infiltrating lymphocytes in Inclusion Body Myositis persists over time: studies in repeated muscle biopsies. Brain 2000;123:2030-2039.
11. Murata K., Dalakas M.C. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNA in inflammatory myopathies. Am. J. Pathol. 1999;155:453-460.
12. Benveniste O., Cherin P., Maisonobe T., et al. Severe perturbations of the blood T cell repertoire in Polymyositis, but not dermatomyositis patients. J. Immunol. 2001;167:3521-3529.
13. Hofbauer M., Wiesner S., Babbe H., et al. Clonal tracking of autoagressive T cells in polymyositis by combining laser microdissection, single-cell PCR and CDR3 spectratype analysis. Proc. Natl. Acad. Sci. USA 2003;100:4090-4095.
14. Dalakas M.C. Molecular Immunology and Genetics of Inflammatory Muscle Diseases. Arch. Neurol. 1998;55:1509-1512.
15. Hohlfeld R., Dalakas M.C. Basic Principles of Immunotherapy in Neurological Diseases. Sem. Neurol. 2003;23:121-132.
16. Dalakas M.C. Therapeutic Approaches in Patients with Inflammatory Myopathies. Sem. Neurol. 2003;23:199-206.